Indiana lawmakers ended their 2026 legislative session without passing a ban on intoxicating hemp products, marking yet another year of failed attempts to regulate products like delta-8 THC and THCA. Senate Bill 250, which sought to mirror recent federal restrictions and establish a 21-plus age requirement for hemp-derived cannabinoids, stalled in the House after passing the Senate with bipartisan support. as first reported by Indiana Capitol Chronicle.
The bill’s failure highlights an ongoing impasse between Indiana’s two legislative chambers over how to approach hemp regulation. For years, products containing intoxicating cannabinoids have existed in a legal gray area, available for purchase without age restrictions despite containing compounds chemically similar to marijuana’s active ingredient.
What Senate Bill 250 Would Have Done
Senate Bill 250, authored by Senator Aaron Freeman (R-Indianapolis), is one of the stricter approaches Indiana has considered for hemp regulation. The legislation aimed to align state law with recent federal changes while establishing full oversight of hemp-derived products.
The bill would have expanded Indiana’s alcohol and tobacco laws to include products containing THC. This expansion covered multiple areas of regulation, including possession by minors and sales to minors. Under the proposed framework, selling or distributing THC-containing products to anyone under 21 would have been classified as a Class B infraction, with enhanced penalties compared to current tobacco violations.
The legislation also designated violations of hemp-derived cannabinoid product regulations as deceptive acts, allowing for additional enforcement mechanisms. The Indiana Alcohol and Tobacco Commission would have been authorized to conduct random inspections at locations selling THC products. Law enforcement officers would have gained the ability to use minors aged 16 and older in compliance checks, similar to current practices for alcohol and tobacco enforcement.
Beyond prohibition measures, Senate Bill 250 outlined a regulatory scheme for low-potency, field-grown hemp products that would remain legal. These products would have been subject to the proposed 21-plus age requirement. The bill specifically excluded CBD from its restrictions, as cannabidiol does not produce intoxicating effects.
The legislation mirrored language from a federal stopgap funding law enacted in November, which specified that all forms of THC count toward legal limits. According to Senator Freeman, that federal law caps THC products at 0.4 milligrams per container and bans laboratory-synthesized cannabinoids. The federal restrictions are set to take effect in November 2026.
Why the Indiana Intoxicating Hemp Ban Bill Failed to Advance
Senate Bill 250 cleared the Senate on January 29th, with a 35-15 vote, showing significant support in that chamber. The bill then moved to the House, where it was referred to the Courts and Criminal Code Committee. On February 19th, the committee reported the bill with amendments and recommended it for passage.
Despite this, the bill never received a second reading on the House floor before a critical Monday deadline on February 24, 2026. Representative Garrett Bascom, the bill’s House sponsor, told the Indiana Capital Chronicle he felt there weren’t enough votes to pass the measure through his chamber this year. He declined to specify particular sticking points but expressed hope for trying again in future sessions.
The legislative timeline reveals a pattern that has plagued hemp regulation efforts in Indiana for years. The state has consistently experienced what observers describe as a House-Senate stalemate over how expansive or limiting hemp regulation should be. This disagreement between chambers has prevented any comprehensive hemp legislation from becoming law since intoxicating hemp products first appeared on the market.
Senator Freeman expressed frustration with the outcome, telling reporters the failed passage was “another example of why we should be a unicameral Legislature.” His comment referred to Indiana’s bicameral system, where both the House and Senate must approve legislation before it can become law.
A last-minute attempt to revive the bill added another twist to the legislative saga. On Thursday, February 26, lawmakers from all four caucuses met in conference committee to discuss inserting the Senate-passed version of Freeman’s bill into Senate Bill 144, a separate piece of legislation regarding tobacco and vapor products. However, when the conference committee report was released Friday afternoon on February 27, the hemp drug ban provisions were notably absent.
Federal and State Context
Indiana’s difficulty passing hemp regulation comes at a time when the federal landscape is also shifting. The 2018 Farm Bill defined legal hemp as any part of the cannabis plant containing less than 0.3% delta-9 THC by dry weight. This definition created what many lawmakers and regulators now call a loophole, as it didn’t account for other intoxicating cannabinoids that could be derived from legal hemp.
Senator Freeman expressed concern about Indiana’s state statute potentially conflicting with federal law once the new federal restrictions take effect in November. While the Supremacy Clause of the U.S. Constitution establishes that federal law supersedes conflicting state law, Freeman noted that practical enforcement varies. He pointed to marijuana legalization in states like California, where state law contradicts federal prohibition, as an example of how federal supremacy doesn’t always translate to uniform enforcement.
“Currently, right, marijuana is illegal, (but) tell that to however many states it’s legalized in,” Freeman said. “Don’t tell that to California; they don’t care. So they’re saying we’re not following federal law. Now, I think that is a really dangerous precedent… And by the way, Indiana is going to be in that category come November, which is all all shades of scary to me.”
Indiana remains among just 10 states that prohibit both medicinal and recreational marijuana sales. The state has consistently resisted legalization efforts, even those supported by Republicans. This conservative stance on cannabis policy makes the state’s inability to regulate intoxicating hemp products particularly notable.
Industry representatives who testified during committee hearings argued that customers wouldn’t want THC products restricted to low potencies that don’t produce psychoactive effects. This testimony suggested that the regulatory framework proposed in Senate Bill 250 might effectively eliminate most hemp-derived cannabinoid products from the market rather than creating a regulated sales system.
What Comes Next?
With the 2026 legislative session concluded, Indiana will go at least another year without age restrictions on intoxicating hemp products. Senator Freeman lamented that lawmakers ended the session “having done nothing” on hemp regulation, leaving the state potentially out of alignment with federal law once the November deadline arrives.
The bill’s sponsor, Representative Bascom, indicated interest in attempting similar legislation in future sessions, though he did not provide specifics about what changes might make passage more likely. The repeated failures suggest that finding compromise between the House and Senate on hemp regulation remains challenging.
Meanwhile, retailers in Indiana continue to sell intoxicating hemp products without verifying buyers’ age, setting potency limits, or providing proper oversight.
In December 2025, President Donald Trump signed an executive order to speed up the process of reclassifying marijuana as a less-dangerous drug under federal law. However, the process remains incomplete. Changing marijuana’s federal scheduling could also complicate hemp regulations further.
For now, the status quo continues. Intoxicating hemp products remain available without the age restrictions, potency limits, and oversight that Senate Bill 250 would have provided. Whether Indiana’s legislators will find common ground in 2027 remains uncertain.
